Tissue Factor and Tissue Factor Pathway Inhibitor in Acute and Chronic Renal Failure

Thromb Haemost 1998; 80(04): 722-724
DOI: 10.1055/s-0037-1615460

Letters to the Editor

Schattauer GmbH

J. Malyszko

¹Department of Nephrology and Internal Medicine, University School of Medicine, Bialystok, Poland

,

J. S. Malyszko

¹Department of Nephrology and Internal Medicine, University School of Medicine, Bialystok, Poland

,

M. Mysliwiec

¹Department of Nephrology and Internal Medicine, University School of Medicine, Bialystok, Poland

References
1 Broze GJ. Jr. Tissue factor pathway inhibitor. Thromb Haemostas 1995; 74: 90-3.
2 Sagripanti A, Barsotti G. Bleeding and thrombosis in chronic uremia. Nephron 1998; 75: 125-39.
3 Malyszko J, Malyszko JS, Pawlak D, Pawlak K, Buczko W, Mysliwiec M. Platelet function, hemostasis and serotonin in acute and chronic renal failure. Thromb Res 1996; 83: 351-61.
4 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imerson JD, Thompson SG. Haemostatic function and ischemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-7.
5 Cella G, Vertolli U, Naso A, Vianello A, Rampin E, Sharai A, Boeri G, Strauss WE. Tissue factor pathway inhibitor (TFPI) activity in uremic patients during hemodialysis. Thromb Res 1996; 81: 671-7.
6 Kario K, Matsuo T, Yamada T, Matsuo M. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis. Thromb Haemostas 1994; 71: 275-9.
7 Kario K, Matsuo T, Matsuo M, Koide M, Yamada T, Nakamura S, Sakata T, Kato H, Miyata T. Marked increase of activated factor VII in uremic patients. Thromb Haemostas 1995; 73: 763-7.
8 Koyama T, Nishida K, Ohdama S, Sawada M, Murakami N, Hirosawa S, Kuriyama R, Matsuzawa K, Hasegawa R, Aoki N. Determination of plasma tissue factor antigen and clinical significance. Brit J Haematol 1994; 87: 343-7.
9 Fukuda C, Iijima K, Nakamura K. Measuring tissue factor (factor III) activity in plasma. Clin Chem 1989; 35: 1897-900.